Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-06-07
1999-11-09
Lovering, Richard D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
264 43, 264 46, 424450, 436829, 514 55, 514851, A61K 4800, A61K 9127
Patent
active
059815019
ABSTRACT:
Plasmid-lipid particles which are useful for transfection of cells in vitro or in vivo are described. The particles can be formed using either detergent dialysis methods or methods which utilize organic solvents. The particles are typically 65-85 nm, fully encapsulate the plasmid and are serum-stable.
REFERENCES:
patent: 4394448 (1983-07-01), Szoka, Jr. et al.
patent: 4438052 (1984-03-01), Weder et al.
patent: 4515736 (1985-05-01), Deamer
patent: 4598051 (1986-07-01), Papahadjopoulos et al.
patent: 4897355 (1990-01-01), Eppstein et al.
patent: 5171678 (1992-12-01), Behr et al.
patent: 5208036 (1993-05-01), Eppstein et al.
patent: 5264618 (1993-11-01), Felgner et al.
patent: 5279833 (1994-01-01), Rose
patent: 5283185 (1994-02-01), Epand et al.
patent: 5320906 (1994-06-01), Eley et al.
patent: 5545412 (1996-08-01), Eppstein et al.
M. Barinaga: "Gene Therapy--Step Taken Toward Improved Vectors for Gene Transfer", Science, vol. 266, Nov. 1994, p. 1326.
E. Marshall: "Gene Therapy's Growing Pains", Science, vol. 269, Aug. 1995, pp. 1050-1055.
R. Crystal: "Transfer of Genes to Humans: Early Lessons and Obstacles to Success", Science, vol. 270, 1995, pp. 404-410.
S. H. Orkin et al: Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy, NIH Report, Dec. 1995.
Hawley-Nelson, et al. Focus 15(3):73 (1993) Lipofectamine.TM.Reagent: A New, Higher Efficiency Polycationic Liposome Transfection Reagent.
Stamatatos, et al., Biochemistry 27:3917-3925 (1988), Interactions of Cationic Lipid Vesicles with Negatively Charged Phospholipid Vesicles and Biological Membranes.
Leventis, et al., Biochem. Biophys. Acta 1023:124 (1990), Interactions of Mammalian Cells with Lipid Dispersions Containing Novel Metabolizable Cationic Amphiphiles.
Ballas, et al., Biochim. Biophys. Acta 939:8-18 (1988).
Duzgunes, Subcellular Biochemistry 11:195-286 (1985).
Szoka et al., Ann. Rev. Biophys. Bioeng. 9:467-508 (1980).
Legendre, Pharm. Res. 9:1235-1242 (1992).
Gao, et al., Biochem. Biophys. Res. Comm. 179:280-285 (1991).
Woodle, et al., Biochim. Biophys. Acta 1105:193-200 (1992), Versatility in Lipid Compositions Showning Prolonged Circulation with Sterically Stabilized Liposomes.
Juliano, Biochem. Biophys. Res. Commun. 63:651-658 (1975).
Zhu, et al., Science 261:209-211 (1993), Systemic Gene Expression After Intravenous DNA Delivery Into Adult Mice.
Hyde et al., Nature 362:250-256 (1993), Correction of the Ion Transport Defect in Systic Fibrosis Transgenic Mice by Gene Therapy.
Brigham, et al., Am. J. Med. Sci. 298:278-281 (1989), Rapid Communication: In Vivo Transfection of Murine Lungs with a Fuctioning Prokaryotic Gene Using a Liposome Vehicle.
Puyal et al., Eur. J. Biochem. 228:697-703 (1995).
Bally Marcel B.
Cullis Pieter R.
Hope Michael
Wheeler Jeffery J.
Inex Pharmaceuticals Corp.
Lovering Richard D.
LandOfFree
Methods for encapsulating plasmids in lipid bilayers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for encapsulating plasmids in lipid bilayers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for encapsulating plasmids in lipid bilayers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456058